Ocugen CEO Shankar Musunuri sells 468,727 shares
Both sale entries were reported at a weighted-average price of $0.95, with transaction prices ranging from $0.90 to $0.99.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ocugen, Inc. CEO Shankar Musunuri sold 468,727 shares of common stock directly, and KVM Holdings, LLC sold 57,264 shares indirectly, on October 9, 2026. Each sale was reported at a weighted-average price of $0.95 per share and was made under a Rule 10b5-1 trading plan adopted June 5, 2026. After the transactions, Musunuri directly held 4,018,470 shares, and KVM Holdings held 1,030,771 shares. Musunuri is a member and officer of KVM Holdings and has voting and investment power over its shares.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 468,727 | $0.95 | $445K |
| Sale | Common Stock F1, F3, F4 | 57,264 | $0.95 | $54K |
Footnotes (4)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026
- F2. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- F4. The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
voting and investment power technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What price did the OCGN insider sales report?
When was the Rule 10b5-1 plan for the OCGN sales adopted?
AI-generated analysis. How Rhea-AI works. Not financial advice.